Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Structure-based drug design of 1,3,5-triazine and pyrimidine derivatives as novel FGFR3 inhibitors with high selectivity over VEGFR2.
Bioorg Med Chem. 2020 May 15;28(10):115453. doi: 10.1016/j.bmc.2020.115453. Epub 2020 Mar 28.
Bioorg Med Chem. 2020.
PMID: 32278710
Synthesis and structure-activity relationships of pyrazine-2-carboxamide derivatives as novel echinoderm microtubule-associated protein-like 4 (EML4)-anaplastic lymphoma kinase (ALK) inhibitors.
Iikubo K, Kurosawa K, Matsuya T, Kondoh Y, Kamikawa A, Moritomo A, Iwai Y, Tomiyama H, Shimada I.
Iikubo K, et al.
Bioorg Med Chem. 2019 Apr 15;27(8):1683-1692. doi: 10.1016/j.bmc.2019.03.018. Epub 2019 Mar 7.
Bioorg Med Chem. 2019.
PMID: 30878193
Item in Clipboard
Synthesis and structure-activity relationships of pyrimidine derivatives as potent and orally active FGFR3 inhibitors with both increased systemic exposure and enhanced in vitro potency.
Kuriwaki I, Kameda M, Iikubo K, Hisamichi H, Kawamoto Y, Kikuchi S, Moritomo H, Kondoh Y, Terasaka T, Amano Y, Tateishi Y, Echizen Y, Iwai Y, Noda A, Tomiyama H, Nakazawa T, Hirano M.
Kuriwaki I, et al. Among authors: iikubo k.
Bioorg Med Chem. 2021 Mar 1;33:116019. doi: 10.1016/j.bmc.2021.116019. Epub 2021 Jan 16.
Bioorg Med Chem. 2021.
PMID: 33486159
Item in Clipboard
Discovery of ASP5878: Synthesis and structure-activity relationships of pyrimidine derivatives as pan-FGFRs inhibitors with improved metabolic stability and suppressed hERG channel inhibitory activity.
Kuriwaki I, Kameda M, Iikubo K, Hisamichi H, Kawamoto Y, Kikuchi S, Moritomo H, Terasaka T, Iwai Y, Noda A, Tomiyama H, Kikuchi A, Hirano M.
Kuriwaki I, et al. Among authors: iikubo k.
Bioorg Med Chem. 2022 Apr 1;59:116657. doi: 10.1016/j.bmc.2022.116657. Epub 2022 Feb 11.
Bioorg Med Chem. 2022.
PMID: 35219181
Item in Clipboard
Discovery of N-{2-Methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}-N'-[2-(propane-2-sulfonyl)phenyl]-1,3,5-triazine-2,4-diamine (ASP3026), a Potent and Selective Anaplastic Lymphoma Kinase (ALK) Inhibitor.
Iikubo K, Kondoh Y, Shimada I, Matsuya T, Mori K, Ueno Y, Okada M.
Iikubo K, et al.
Chem Pharm Bull (Tokyo). 2018;66(3):251-262. doi: 10.1248/cpb.c17-00784.
Chem Pharm Bull (Tokyo). 2018.
PMID: 29491259
Free article.
Item in Clipboard
Synthesis and structure-activity relationship of fused-pyrimidine derivatives as a series of novel GPR119 agonists.
Negoro K, Yonetoku Y, Moritomo A, Hayakawa M, Iikubo K, Yoshida S, Takeuchi M, Ohta M.
Negoro K, et al. Among authors: iikubo k.
Bioorg Med Chem. 2012 Nov 1;20(21):6442-51. doi: 10.1016/j.bmc.2012.08.054. Epub 2012 Sep 7.
Bioorg Med Chem. 2012.
PMID: 23010456
Item in Clipboard
Biological activities of alpha-mangostin derivatives against acidic sphingomyelinase.
Hamada M, Iikubo K, Ishikawa Y, Ikeda A, Umezawa K, Nishiyama S.
Hamada M, et al. Among authors: iikubo k.
Bioorg Med Chem Lett. 2003 Oct 6;13(19):3151-3. doi: 10.1016/s0960-894x(03)00719-4.
Bioorg Med Chem Lett. 2003.
PMID: 12951083
Item in Clipboard
Cite
Cite